These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 34468195)

  • 1. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
    Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
    Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.
    Domon H; Maekawa T; Yonezawa D; Nagai K; Oda M; Yanagihara K; Terao Y
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181369
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae.
    Domon H; Hirayama S; Isono T; Sasagawa K; Takizawa F; Maekawa T; Yanagihara K; Terao Y
    Microbiol Spectr; 2023 Jun; 11(3):e0014823. PubMed ID: 37191519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
    Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
    BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
    Anderson R; Steel HC; Cockeran R; Smith AM; von Gottberg A; de Gouveia L; Brink A; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
    Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
    J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.
    Majhi A; Adhikary R; Bhattacharyya A; Mahanti S; Bishayi B
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5164-80. PubMed ID: 24957840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.
    Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L
    J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
    Yasuda Y; Kasahara K; Mizuno F; Nishi K; Mikasa K; Kita E
    Antimicrob Agents Chemother; 2007 May; 51(5):1741-52. PubMed ID: 17353244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.
    Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R
    Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
    Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
    mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.
    Price KE; Camilli A
    J Bacteriol; 2009 Apr; 191(7):2163-8. PubMed ID: 19168620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A.
    Song M; Teng Z; Li M; Niu X; Wang J; Deng X
    J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin.
    Jacques LC; Panagiotou S; Baltazar M; Senghore M; Khandaker S; Xu R; Bricio-Moreno L; Yang M; Dowson CG; Everett DB; Neill DR; Kadioglu A
    Nat Commun; 2020 Apr; 11(1):1892. PubMed ID: 32312961
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
    mSphere; 2018; 3(3):. PubMed ID: 29720526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
    Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
    Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Aquaporin Subfamily Imports Oxygen and Contributes to Pneumococcal Virulence by Controlling the Production and Release of Virulence Factors.
    Hu Q; Tong H; Wang J; Ge P; Zhu L; Liu C; Zhang JR; Dong X
    mBio; 2021 Aug; 12(4):e0130921. PubMed ID: 34399618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae.
    Fukuda Y; Yanagihara K; Higashiyama Y; Miyazaki Y; Hirakata Y; Mukae H; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
    Eur Respir J; 2006 May; 27(5):1020-5. PubMed ID: 16455827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.
    Salha D; Szeto J; Myers L; Claus C; Sheung A; Tang M; Ljutic B; Hanwell D; Ogilvie K; Ming M; Messham B; van den Dobbelsteen G; Hopfer R; Ochs MM; Gallichan S
    Infect Immun; 2012 Jun; 80(6):2212-20. PubMed ID: 22473606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.